Can taking a GLP-1 medication lower my cancer risk?

Oct 7, 2026

Key takeaways:

GLP-1s are a group of medications that mimic your body’s natural GLP-1 hormone, which is responsible for regulating your blood sugar levels, hunger and digestion.
Everyone produces GLP-1 naturally, but some people don’t make enough or don’t respond to it effectively. GLP-1 medications strengthen and extend the hormone’s effects.
Current research shows a strong correlation between GLP-1 use and cancer risk, not proven causation. Today, their primary purpose remains managing diabetes and supporting weight loss for people who need it.

A new era of weight-loss medication has arrived, and its popularity has surged in recent months. GLP-1 (Glucagon-Like Peptide-1 receptor agonists) medications are used for weight loss but are also being prescribed widely to treat conditions affected by weight, including type 2 diabetes and certain cardiovascular issues.

Their brand names, Ozempic, Wegovy, Zepbound and others, have entered the spotlight due to growing public interest and highly-visible weight loss stories, while emerging research has highlighted significant health benefits, especially for people with weight-related conditions. One potential effect researchers are exploring is their relationship to cancer risk. Here’s what we know so far about GLP-1s and cancer:

How do GLP-1 medications work?

GLP-1s are a group of medications that mimic your body’s natural GLP-1 hormone, which is responsible for regulating your blood sugar levels, hunger and digestion. The medication is most often administered by injection, normally in areas where fatty tissue is more present like your stomach, outer thighs, upper glutes or the backs of your arms.

Everyone produces GLP-1 naturally, but some people don’t make enough or don’t respond to it effectively. GLP-1 medications strengthen and extend the hormone’s effects, providing steadier blood sugar control and more consistent appetite regulation than the natural hormone alone.

The GLP-1 hormone does several things for your body:

Triggers insulin release: Insulin is a hormone that allows your body to use the food you eat for energy. It manages the amount of glucose (sugar) in your blood. If you don’t have enough insulin, your blood sugar increases; over time, this can lead to diabetes.
Reduces glucagon release: Glucagon is a hormone your body uses to raise your blood sugar levels when necessary. GLP-1 prevents extra stored glucose from going into your bloodstream.
Slows digestion: Slower digestion means that your body releases less glucose from the food you eat into your bloodstream.
Triggers satiety: GLP-1 affects areas of your brain that process hunger and satiety (how full you feel after eating).

The first two points are why GLP-1s are prescribed to patients with type 2 diabetes, which is a chronic condition where your body either resists the effects of insulin or doesn’t produce enough.

The second two points are what cause the weight-loss effects of GLP-1s, which is why patients who are overweight or have obesity may be prescribed these medications to reduce their risk of obesity-related health issues.

Do GLP-1 medications reduce cancer risk?

Recent research shows GLP-1 medications affect cancer risk in two ways: GLP-1s reverse cancer risk associated with excess weight, and they also seem to have anti-inflammatory effects that help suppress tumors.

Obesity is known to increase the risk of at least 13 different cancer types, which is why losing weight (for someone who is clinically obese) can have such an impact on preventing cancer.

Several studies on this topic were published and presented at the 2026 American Society of Clinical Oncology (ASCO) meeting, the most prominent study revealing that GLP-1s reduced cancer risk at significant levels for پستان, colorectal, کبد و ریه cancers, somewhat reduced risk for kidney and prostate cancers, and affected pancreatic cancer risk the least.

Another study presented at ASCO found that GLP-1 medications are linked to a lower incidence rate of breast cancer among women of screening age.

Related to tumor progression, one study revealed that GLP-1s were able to slow the progression of four different obesity-related cancer types: breast, colorectal, liver and lung cancers.

It’s important to understand current research shows a strong correlation between GLP-1 use and cancer risk, not proven causation. In other words, the two appear connected, but scientists have not yet confirmed that one directly causes changes in the other. GLP-1s may one day play a more significant role in cancer prevention, but right now they are only recommended for people who need them to manage diabetes or support weight loss for medical reasons.

Are there health risks associated with taking GLP-1 medications?

Like every medication, there are side effects when taking GLP-1s. Some of the most common side effects include:

Gastrointestinal issues (nausea, vomiting, diarrhea, constipation, pain or bloating)
Injection site reactions
Increased heart rate
Appetite changes or weight loss
Indigestion or heartburn
Headache
Dizziness
خستگی
Hair loss

There are other less common but more serious related health risks possible when taking GLP-1 medications, such as gallbladder problems, pancreatitis, bone loss and kidney damage.

In addition to these side effects, all GLP-1 medications carry a boxed warning for the potential risk of thyroid cancer. These warnings are based on animal studies, and this risk has not been confirmed in people. But, health care professionals advise people with a personal or family history of thyroid cancer avoid taking GLP-1s.

If you are taking a GLP-1 medication, you can reduce your risk of thyroid cancer by:

Discussing your personal and family health history with your health care provider before starting any medication.
Watch for signs and symptoms such as any lumps, swelling or changes in your neck and tell your health care provider immediately if you notice a change.
Follow up regularly with your health care provider to monitor your thyroid health during treatment.

Will GLP-1 medications become a cancer prevention method?

It is a possibility, but we need more research and dedicated clinical trial data before GLP-1s can be approved or recommended as a cancer prevention or cancer treatment tool. Since much of the current data is circumstantial, meaning cancer risk was likely lowered due to weight loss, the Food and Drug Administration (FDA) has not approved GLP-1s for the purpose of reducing cancer risk.

Obesity continues to be a leading risk factor for cancer. If research continues to show positive findings for GLP-1 use and cancer risk, this could give many people a chance at better health outcomes.

In the meantime, whether you’re considering a GLP-1 or not, you can prioritize habits that can help you maintain a healthy body weight, like getting regular physical activity and eating a well-balanced diet, to reduce your cancer risk.

همچنین بخوانید | How sleep and fitness affect your health

As research continues to evolve, GLP‑1 medications may one day play a role in cancer prevention—but today, their primary purpose remains managing diabetes and supporting weight loss for people who need it.

What’s certain is that understanding the steps you can take to maintain a healthy lifestyle and staying informed about ways to reduce your cancer risk can help you make decisions that support your long‑term health.